In a recent study, hPCL3S has been shown to be up-regulated in hepatocarcinoma tumors (HCC) and cell lines and to promote their growth and migration through activation of the β-catenin/IL-6 pathway [25]. Here, IL6 is linked to hepatocellular carcinoma.